Amgen · 14 hours ago
Executive Director, Contracts & Pricing Strategy – Oncology & Ophthalmology
United States
Full-time
Remote
Director/Executive
$279K/yr - $323K/yr
12+ years expAmgen is a leading biotechnology company focused on serving patients living with serious illnesses. The Executive Director, Contracts & Pricing Strategy – Oncology & Ophthalmology will be responsible for setting and executing U.S. payer and provider contracting, pricing, and access strategies across Amgen’s Oncology and Ophthalmology portfolios.
BiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Own and execute U.S. payer and provider contracting and pricing strategy across the Oncology and Ophthalmology portfolios, ensuring consistency where appropriate while accounting for therapeutic, site-of-care, and channel-specific dynamics
Establish portfolio-level contracting guardrails, decision frameworks, and governance to guide brand-level execution and tradeoff decisions
Serve as a member of the Oncology Leadership Core Team, contributing to cross-portfolio strategy and execution across the business unit
In partnership with Brand, Finance, and CD&A teams, provide forecasted coverage, pricing, and GTN assumptions into: Quarterly Latest Estimate Discount Rate (LEDR), Quarterly Business Reviews (QBRs), Long-Range Scenario (LRS) planning including clear messaging for executive leadership
Lead proactive support for bi-annual strategic planning and quarterly performance reviews
Manage budgets for all value-related workstreams across the Oncology and Ophthalmology portfolios
Coach and empower teams to develop comprehensive coverage and net price plans for each product, including: Core pricing and access assumptions, Payer and provider contract platforms, Pull-through and execution resources for Market Access teams
Collaborate with Patient Access and Brand teams to maintain and evolve patient support programs in real time to address access barriers and pull-through opportunities
Partner with Value Marketing to develop therapeutic-area-specific value strategies, messaging, tools, and evidence generation plans aligned with brand strategy
Collaborate with Training, Brand, and Sales to develop Market Access Team and field meeting content, semester plans of action, and coverage goals
Lead assessment and strategic response to U.S. pricing and reimbursement policy changes, including IRA implications, Medicare negotiation, inflation rebates, ASP dynamics, and 340B considerations
Apply deep understanding of the buy-and-bill value chain, including GPOs, wholesalers, large provider networks, and health systems
Liaise with the Biosimilars Business Unit and Global Oncology and Ophthalmology teams to inform pipeline strategy, lifecycle planning, and forecast assumptions
Support business development and due diligence activities related to pricing, access, and GTN considerations
Serve as a senior pricing and access leader in key payer, provider, GPO, and health system engagements
Triage and resolve contracting and pricing-related issues for Sales and Market Access teams, ensuring timely resolution and appropriate training where needed
Develop and deliver concise, executive-ready communications for senior leadership
Qualification
Required
Doctorate degree and 6 years of marketing, sales management, pricing, or payer experience, OR
Master's degree and 10 years of marketing, sales management, pricing, or payer experience, OR
Bachelor's degree and 12 years of marketing, sales management, pricing, or payer experience AND
6 years of managerial experience, including direct people leadership and/or leading complex cross-functional teams, programs, or resource allocation
Preferred
Experience leading large, complex teams and delivering results in highly competitive markets
Experience developing strategies to optimize payer and provider coverage, access, and net price
Understanding of U.S. pricing and reimbursement, including Medicare Part B, IRA, ASP, and 340B implications
Experience managing medical benefit gross-to-net forecasting and scenario planning
Experience in Oncology and/or Ophthalmology, or other physician-administered specialty markets
Expertise in buy-and-bill market dynamics, including GPOs, wholesalers, and large provider networks
Ability to conduct qualitative and quantitative pricing analyses to inform price policy and contracting strategy
Experience developing and communicating value narratives aligned with clinical and economic evidence
Ability to lead in a matrixed environment, influencing stakeholders at all levels
Strategic mindset with high intellectual curiosity, creativity, and comfort navigating ambiguity
Executive presence with the ability to deliver clear, credible, and influential communications to senior leadership
Benefits
Comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts.
A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
Stock-based long-term incentives
Award-winning time-off plans and bi-annual company-wide shutdowns
Flexible work models, including remote work arrangements, where possible
Company
Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
10001+ employees
H1B Sponsorship
Amgen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (429)
2024 (485)
2023 (485)
2022 (540)
2021 (460)
2020 (444)
Funding
Current Stage
Public CompanyTotal Funding
$28.5B2022-12-12Post Ipo Debt· $28.5B
1983-06-17IPO
Leadership Team
Robert Bradway
Chairman and Chief Executive Officer
Jay Bradner
Executive Vice President of R&D, and Chief Scientific Officer
Recent News
2026-01-24
2026-01-22
Company data provided by crunchbase